EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of pharmaceutical compositions based on animal and plant-derived squalene

Maria M. Silaenkova, Timur M. Garaev, Ilya I. Yudin, Oleg V. Ledenev, Olesya V. Eliseeva, Oleg E. Latyshev, Anton V. Syroeshkin, Tatyana V. Grebennikova

Journal of Drug Delivery and Therapeutics · 15.06.2026 · 16 (6) · 1-10

DOI: 10.22270/jddt.v16i6.7577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.06.2026. Verfasst von Maria M. Silaenkova und 7 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to develop and evaluate stable pharmaceutical compositions based on squalene derived from both animal (shark liver) and plant (amaranth oil) sources.

Methods

Oil-in-water nanoemulsions were prepared and stored at 4 °C for six months to evaluate stability. Key stability parameters, including droplet size and zeta potential, were determined using Dynamic Light Scattering (DLS). The immunogenicity of VLP-based rotavirus vaccine formulations containing these adjuvants was evaluated in a guinea pig model. Humoral and cellular immune responses were quantified using Enzyme-Linked Immunosorbent Assay (ELISA) for IgG titers, Neutralization Assays (NA) for virus-neutralizing activity, and the Lymphocyte Blast Transformation Reaction (LBTR) to assess cell-mediated immunity.

Results

Both formulations exhibited high stability at 4 °C. Mean droplet diameters were 157 ± 3 nm (animal-derived) and 149 ± 3 nm (plant-derived), which were smaller than the commercial reference (174 ± 4 nm). Zeta potential values (-35 to -39 mV) confirmed robust colloidal stability. Immunization elicited potent responses; no statistically significant differences were observed between the two squalene sources regarding specific IgG titers (GM = 126 267) or virus-neutralizing activity (VNA GM = 640 vs 452.5, p > 0.05). Cellular immunity was induced by both adjuvants, yielding Proliferation Stimulation Index (PSI) values of 3.11 for the plant-derived formulation and 2.10 for the animal-derived variant.

Conclusion

Plant-derived squalene from amaranth oil is a highly effective, sustainable alternative to shark-derived components, providing comparable stability and immunogenic potency for vaccine delivery. Keywords: pharmaceutical compositions, adjuvants, squalene, amaranth oil, nanoemulsions, virus-like particles, VLPs, vaccine formulations.

Zitieren

APA

Silaenkova, M. M., Garaev, T. M., Yudin, I. I., Ledenev, O. V., Eliseeva, O. V., Latyshev, O. E., Syroeshkin, A. V., & Grebennikova, T. V. (2026). Development of pharmaceutical compositions based on animal and plant-derived squalene. Journal of Drug Delivery and Therapeutics, 16(6), 1-10. https://doi.org/10.22270/jddt.v16i6.7577

Vancouver

Silaenkova MM, Garaev TM, Yudin II, Ledenev OV, Eliseeva OV, Latyshev OE, et al. Development of pharmaceutical compositions based on animal and plant-derived squalene. Journal of Drug Delivery and Therapeutics. 2026;16(6):1-10. doi:10.22270/jddt.v16i6.7577

BibTeX
@article{Silaenkova2026,
  author = {Silaenkova, Maria M. and Garaev, Timur M. and Yudin, Ilya I. and Ledenev, Oleg V. and Eliseeva, Olesya V. and Latyshev, Oleg E. and Syroeshkin, Anton V. and Grebennikova, Tatyana V.},
  title = {Development of pharmaceutical compositions based on animal and plant-derived squalene},
  journal = {Journal of Drug Delivery and Therapeutics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {1--10},
  doi = {10.22270/jddt.v16i6.7577}
}
Kostenlos starten →